City-based pharmaceutical major, Zydus Cadila announced completion of the single ascending dose (SAD) study of ZYAN1 molecule as part of phase-1 study ongoing in Australia. The molecule, ZYAN1 is an orally bioavailable hypoxia-inducible ... Hindu Business Line, 1 week ago
Zydus completes single rising dose Phase I studies for its oral HIF inhibitor, ZYAN1 - Money Control, 1 week ago
Zydus completes single ascending dose Phase I trial of anaemia drug ZYAN1 - Pharmaceutical Business Review, 1 week ago
3 images for "zydus cadila"
Firstcall Research's report on Cadila Healthcare For the 3rd quarter ended Dec 31st, 2014, Zydus Cadila reported Net sales of Rs 21894.60 mn, up by 16.98% from Rs. 18716.90 mn in the corresponding quarter of the previous year on a consolidated ...Moneycontrol.com, 1 week ago Buy Cadila Healthcare; target of Rs 1715: Firstcall Moneycontrol.com, 2 months ago
The consumer products arm of Ahmedabad-based pharmaceutical major Cadila Healthcare, Zydus Wellness, is planning to up its ante in the personal care segment where it sells its products under the Everyuth brand. The company which has recently ...Business Standard India, 1 week ago Zydus Wellness launches herbal variant of Sugar Free Business Standard India, 2 weeks ago
Cadila Healthcare Ltd (Zydus Cadila) has reported a sharp jump of 52 per cent on the consolidated net profit of ₹282 crore for the quarter ended December 2014 against ₹186 crore in the corresponding period last year. Total income from ...Hindu Business Line, 2 weeks ago Zydus Cadila Q3 net jumps 52% Hindu Business Line, 2 weeks ago Zydus Cadila Net Profit up by 52% in Q3 FiercePharma, 2 weeks ago Cadila Healthcare net jumps by 52% in Q3 to Rs. 282 cr PharmaBiz, 2 weeks ago
AHMEDABAD: Zydus Cadila group will be making an oral presentation on Saroglitazar, a novel compound under development for treatment in Non-alcoholic Steatohepatitis (NASH), at the Keystone Symposium on Liver Metabolism and Non-alcoholic Fatty Liver ...Times of India, 3 weeks ago Cadila Healthcare intimates presentation of Saroglitazar for treatment of NASH Business Standard India, 3 weeks ago Indian company Zydus to present data on Lipaglyn in steatohepatitis Pharma Letter, 2 weeks ago Zydus to present data from Saroglitazar to treat NASH at Keystone Symposium PharmaBiz, 3 weeks ago
More from: , Smart Investor...and 2 other sources
The US Food and Drug Administration (USFDA) has notified that Zydus Pharmaceuticals USA , the US subsidiary of Cadila Healthcare , has voluntarily recalled 19,536 bottles of benzonatate capsules. The drug indicated for the treatment ...4 Traders, 1 month ago Cadila recalls 19,536 bottles of cough treatment drug in US Business Standard India, 1 month ago Cadila recalls cough treatment drug in U.S. The Hindu, 1 month ago Cadila Healthcare recalls cough treatment drug in US Indian-Commodity, 1 month ago
Zydus Cadila announced the launch of its biosimilar Adalimumab, following an approval from the Drug Controller General (India). According to a press release, the biosimilar was developed by researchers at the Zydus Research Centre. To be marketed ...Financial Express, 2 months ago Humira biosimilar released in India Pharmafocus, 2 months ago Zydus Launches Biosimilar For Auto Immune Disorder Drug Business Standard, 2 months ago Zydus Cadila launches first cheaper copy of worlds topselling drug Hindustan Times, 2 months ago
Corporate majors like Cadila Healthcare Ltd and Torrent Group were among the top donors from Gujarat to have contributed to the election kitty of Indian National Congress (INC) and Nationalist Congress Party (NCP) for the 2014 Lok Sabha elections. ...Hindu Business Line, 2 months ago CADILA HEALTHCARE : Torrent, Cadila among donors to Cong, NCP 4 Traders, 2 months ago Torrent Group & Cadila Healthcare among top political donors from Gujarat during 2013-14 Indian Express, 2 months ago Torrent Group, Cadila Healthcare among top political donors from Gujarat; BJP only defaulter Financial Express, 2 months ago
Zydus Cadila launched the biosimilar version of Adalimumab, which is the world's first biosimilar made end-to-end in India. Sharvil Patel, Deputy MD, Cadila Healthcare says the important this is to look at access or affordability.Money Control, 2 months ago Zydus launches world's first biosimilar of Adalimumab Money Control, 2 months ago
Ebolavirus under an electron microscope--Courtesy of CDC The latest drugmaker diving into the Ebola vaccine race? India's Zydus Cadila. The pharma is developing jabs for the deadly virus and tick-borne viral Crimean-Congo hemorrhagic fever, The ...FierceVaccines, 1 month ago Zydus Cadila developing Ebola, Congo fever vaccines Times of India, 1 month ago
on your WebpageAdd Widget >Get your members hooked!